Keep These Firms on Your Shopping List
Household-product firms have recovered nicely from past troubles.
Research has demonstrated that shoppers who use a list while grocery shopping are more likely to have lower grocery bills over time, because having a list reduces the inclination to make spontaneous purchases of less-needed items. Given our preference for buying stocks on sale, however, we're unlikely right now to make any spontaneous purchases of household and personal care (HHPC) stocks. Except for one terrific exception in Procter & Gamble (PG) (see last month's article, "Why P&G Looks Like a Buy"), we believe most of the consumer-products stocks we cover--including Alberto-Culver (ACV), Colgate (CL), Clorox (CLX), Kimberly-Clark (KMB), Energizer (ENR), Playtex (PYX), and Newell Rubbermaid (NWL)--are fairly valued. Some of them have been on sale in the past, however, namely Colgate and Kimberly-Clark, and there are some compelling reasons to keep them on your shopping list should they go on sale again. After several challenging years, these companies are fundamentally healthier now, and as providers of staples consumers use every day, they'll be less susceptible to economic fluctuations.
Trouble in the Cupboard
Over the past several years, there's been a fair amount of turmoil for the manufacturers of ho-hum products like detergent, shampoo, batteries, and toothpaste. The biggest impact has been from commodity cost increases, with raw material prices for oil, natural gas, resin, pulp, and zinc rising dramatically and torpedoing profitability. HHPC firms have struggled to find cost savings and push through price increases to keep gross margins from eroding. It's no surprise then that over the past several years these firms have had to take a good hard look at their manufacturing cost structures and restructure their operations in order to find savings to offset these input costs. Whether outsourcing manufacturing to third-party vendors with lower overhead costs, or closing plants in mature markets and building them in lower-cost developing markets that are closer to future growth opportunities, none of the HHPC firms have been immune to some sort of cost-cutting or restructuring, as the examples below illustrate:
Lauren DeSanto does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.